首页 › 基金 › Duquesne Family Office LLC › RGEN
Duquesne Family Office LLC 对 RGEN 的持仓历史
REPLIGEN CORP · 医疗保健
Duquesne Family Office LLC 在 Q3 2026 的 13F 申报中披露持有 RGEN(REPLIGEN CORP)77,400 股,市值约 US$14.9M,约占其申报组合的 0.40%,在其申报持仓中市值排名第 44 位。 Duquesne Family Office LLC 最近 2 个申报季度中有 2 个季度披露了 RGEN 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Duquesne Family Office LLC 对 RGEN 的持仓演变
Duquesne Family Office LLC 于 Q2 2026 首次披露 RGEN 持仓:77,400 股(约 US$10.6M)。 该持仓在 Q3 2026 达到峰值 77,400 股,市值约 US$14.9M。 在 2 次申报中,Duquesne Family Office LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 77,400 股、市值约 US$14.9M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 77.40K | $10.56M | 新进 |
| Q3 2026 | 77.40K | $14.88M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RGEN 与 13F 数据
RGEN(REPLIGEN CORP)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 RGEN,申报仓位最大的包括:UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), MAVERICK CAPITAL LTD (US$272.5M), Maverick 资本 (US$270.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RGEN 的基金
- UNITED CAPITAL FINANCIAL ADVISORS, LLC 2.79M 股 · $536.33M · Q3 2026
- MAVERICK CAPITAL LTD 1.42M 股 · $272.48M · Q3 2026
- Maverick 资本 1.98M 股 · $270.77M · Q2 2026
- RTW INVESTMENTS, LP 1.39M 股 · $266.32M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.24M 股 · $239.02M · Q3 2026
- CONGRESS ASSET MANAGEMENT CO 1.02M 股 · $196.25M · Q3 2026
- Stephens Investment Management Group LLC 954.52K 股 · $183.49M · Q3 2026
- WASATCH ADVISORS LP 907.16K 股 · $174.38M · Q3 2026
- BAMCO INC /NY/ 740.91K 股 · $142.42M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 734.87K 股 · $141.26M · Q3 2026
- Conestoga Capital Advisors, LLC 700.63K 股 · $134.68M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 591.71K 股 · $113.74M · Q3 2026
更多关于 Duquesne Family Office LLC
常见问题
How long has Duquesne Family Office LLC held RGEN?
Duquesne Family Office LLC has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Duquesne Family Office LLC's current position in RGEN?
As of Q3 2026, Duquesne Family Office LLC holds 77.40K shares of RGEN (REPLIGEN CORP), valued at $14.88M, representing 0.40% of its reported portfolio and ranking #44.
Has Duquesne Family Office LLC been buying or selling RGEN?
In the latest 13F filing (Q3 2026), Duquesne Family Office LLC held unchanged its position in RGEN. The position peaked in Q3 2026 at 77.40K shares.
Which other funds hold RGEN?
Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, MAVERICK CAPITAL LTD, Maverick 资本, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.